Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Angaran, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Angaran, D.
American Journal of Hospital Pharmacy, Vol 48, Issue 9, 1931-1937
Copyright © 1991 by American Society of Health-System Pharmacists


Articles

Selecting, developing, and evaluating indicators

DM Angaran


A process for selecting and evaluating indicators for use in monitoring the quality of patient care is described. An indicator is a quantitative measure that provides information and reveals ways in which care could be improved. It is a specific set of conditions whose presence signals that the care being provided should be examined. A sample medication-use outcome indicator is discussed to illustrate the steps of indicator evaluation in a paradigm proposed by the National Demonstration Project on Quality Improvement in Health Care. Indicators must be selected according to the needs of the institution: the frequency with which the set of conditions is likely to occur, the risk involved, and the institution's goals and capabilities. Documented data on the indicator must exist and must be adequate for evaluation of care. Analysis and interpretation of the data and a plan for using the information are discussed. For the use of indicators to succeed in improving the quality of care, the total institution must be committed to the process. Pharmacy quality assurance efforts need to move from evaluation of the use of specific drugs (i.e., focus on the product) to continuous measuring, monitoring, and quality improvement.
 



This article has been cited by other articles:


Home page
J Oncol Pharm PractHome page
A. Aldaz Pastor, I. T. de la Asuncion, C. Gonzalez-Criado, and A. Idoate Garcia
Clinical pharmacokinetics in oncology: Outcome in vancomycin
Journal of Oncology Pharmacy Practice, January 1, 1996; 2(3): 139 - 146.
[Abstract] [PDF]


Home page
American Journal of Medical QualityHome page
T. A. Joiner and S. H. Nelson
Quality Assurance in the Department of Pediatrics: An Application of Quality Management
American Journal of Medical Quality, September 1, 1993; 8(3): 152 - 160.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society of Health-System Pharmacists.